ApprovalTrail

Approval · Notice of Compliance 23760 · 2020

LONGRANGE: Notice of Compliance 23760

Issued June 10, 2020

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
23760
Date
June 10, 2020
Company
Boehringer Ingelheim Animal Health Canada Inc.Burlington, Ontario, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Administrative: Manufacturer Name Change

Products in this notice

BrandDINStatus today
LONGRANGE02450798Marketed

Medicinal ingredients